Big Health announced on 8 August it has received US Food and Drug Administration clearance for its digital therapeutic (DTx), SleepioRx, for treating chronic insomnia as an adjunct to usual care for patients ages 18 and older.
Big Health Gets Good Night Sleep With FDA Approval Of Insomnia Digital Therapeutic
Big Health announced it received FDA clearance for its digital therapeutics for insomnia and hopes a new CMS fee schedule will pave the way to reimbursement.
More from Approvals
More from Policy & Regulation
• By
Calley Means defended reductions in force at the Health and Human Services Department that shocked and outraged federal workers and stakeholders.
• By
Some employees were not impressed with FDA Commissioner Martin Makary's first speech to the agency staff, saying he did not seem to understand the agency's mission.
• By
Swiss medtech exporters seek urgent diplomatic action from the Swiss Federal Council in a bid to overturn the 2 April US decision to put tariffs on goods imports.